16 Additional Chikungunya Related Fatalities Reported in Brazil

According to the Pan American Health Organization (PAHO) chikungunya data dashboard, the Federative Republic of Brazil has reported 16 additional fatalities related to chikungunya virus (CHIKV) disease outbreaks in one month.

As of October 6, 2024, Brazil has confirmed 177 fatalities and 394,739 CHIKV cases this year.

Data from Brazil's Ministry of Health indicates that Minas Gerais has reported the most chikungunya cases, over 160,000, followed by Mato Grosso and Bahia.

Minas Gerais is Brazil's fourth-largest state by area, with a population exceeding 20 million.

In 2023, Brazil welcomed about 6 million foreign tourists, many visiting Minas Gerais.

The U.S. CDC confirmed in September 2024 that there has been evidence of chikungunya virus transmission in Brazil within the last five years, and vaccination may be considered for certain visitors.

As of October 6, 2024, Valneva SE's IXCHIQ® chikungunya vaccine has been approved by the U.S. Food and Drug Administration and recommended for travelers to endemic areas by the CDC.

IXCHIQ is commercially available at travel clinics and pharmacies in the U.S.